Pisani, A., Riccio, E., Sabbatini, M., Andreucci, M., Del Rio, A. and Visciano, B. (2014) Effect of Oral Liposomal Iron versus Intravenous Iron for Treatment of Iron Deficiency Anaemia in CKD Patients: A Randomized Trial. Nephrology Dialysis Transplantation, 30, 645-652.
https://doi.org/10.1093/ndt/gfu357

has been cited by the following article:

• TITLE: Liposomal Iron for Iron Deficiency Anemia in Women of Reproductive Age: Review of Current Evidence

  AUTHORS: Parag Biniwale, Bhaskar Pal, Tripura Sundari, Gorakh Mandrupkar, Nikhil Datar, Amandeep Singh Khurana, Amit Qamra, Salman Motlekar, Rishi Jain

  KEYWORDS: Liposomal Iron, Microencapsulated, Micronized, Iron Deficiency, Anemia, Pregnancy

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.8 No.11, September 11, 2018

  ABSTRACT: Iron deficiency anemia is the most frequent nutritional deficiency disorder. Conventionally administered oral iron is associated with gastrointestinal intolerance that affects the outcomes and compliance. Liposomal iron is associated with increased absorption without causing significant adverse effects. In this review, we have discussed the technology of liposomal iron preparation, mechanisms of its absorption and clinical evidence on its utility in iron deficiency states in pregnant and non-pregnant women. Based on the available evidence, we compared liposomal iron to conventional oral iron. Encapsulation of micronized iron in liposomes is associated with lesser exposure to gastric contents, lesser interaction with food contents, no exposure to different digestive juices, targeted delivery of iron and allows lower doses to be administered in lieu of direct absorption without need for protein carriers. The available evidence suggests that liposomal iron significantly increases hemoglobin, ferritin levels in pregnant women as well as in women with iron deficiency.